Regulation of MHC class II expression in the central nervous system

Microbes and Infection

Volumn 1, Issue 11, 1999, Pages 893-902

  Collawn, James F ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLERGIC ENCEPHALITIS; APOPTOSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

EID: 0032742404     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00228-2     Document Type: Article

References (110)

1. Aloisi F., Ria F., Penna G., Adorini L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160:1998;4671-4680.
2. Baker C.F., Billingham R.F. Immunologically privileged sites. Adv. Immunol. 25:1977;1-49.
3. Benveniste E.N. Cytokines: Influence on glial cell gene expression and function. Blalock J.E. Neuroimmunoendocrinology. 1997;31-75 Karger Basel.
4. Benveniste E.N. Role of macrophages/microglia in multiplesclerosis and experimental allergic encephalomyelitis. J. Mol. M. 75:1997;165-173.
5. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:1998;3299-3306.
6. Blum J.S., Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA. 85:1988;3975-3979.
7. Brocke S., Gijbels K., Allegretta M., Ferber I., Piercy C., Blankenstein T., Martin R., Utz U., Karin N., Mitchell D., Veromaa T., Waisman A., Gaur A., Conlon P., Ling N., Fairchild P.J., Wraith D.C., O'Garra A., Fathman C.G., Steinman L. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature. 379:1996;343-346.
8. + T lymphocytes in the central nervous system. Clin. Exp. Immunol. 98:1994;313-318.
9. Chang C.H., Flavell R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. M. 181:1995;765-767.
10. Chang C.H., Guerder S., Hong S.C., VanEwijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:1996;167-178.
11. Chen L.Z., Hochwald G.M., Huang C., Dakin G., Tao H., Cheng C., Simmons W.J., Dranoff G., Thorbecke G.J. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-β1. Proc. Natl. Acad. Sci. USA. 95:1998;12516-12521.
12. Chin K.C., Mao C., Skinner C., Riley J.L., Wright K.L., Moreno C., Stark G.R., Boss J.M., Ting J.P.Y. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity. 1:1994;687-697.
13. Constam D.B., Philipp J., Malipiero U.V., TenDijke P., Schachner M., Fontana A. Differential expression of transforming growth factor-β1 -β2 and -β3 by glioblastoma cells astrocytes and microglia. J. Immunol. 148:1992;1404-1410.
14. Cresswell P. Getting peptides into MHC class II molecules. Curr. Biol. 4:1994;541-543.
15. Croft M., Bradley L.M., Swain S.L. Naive versus memory CD4 T cell response to antigen: memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152:1994;2675-2685.
16. + T lymphocytes. Proc. Natl. Acad. Sci. USA. 88:1991;6403-6407.
17. + T lymphocytes. J. Immunol. 151:1993;2368-2379.
18. Damle N.K., Klussman K., Linsley P.S., Aruffo A., Ledbetter J.A. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J. Immunol. 149:1992;2541-2548.
19. Dangond F., Windhagen A., Groves C.J., Hafler D.A. Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J. Neuroimmunol. 76:1997;132-138.
20. DeSimone R., Giampaolo A., Giometto B., Gallo P., Levi G., Peschle A.N.D, Aloisi F. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropath. Exp. Neurol. 54:1995;175-187.
21. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell. 82:1995;155-165.
22. Devajyothi C., Kalvakolanu I., Babcock G.T., Vasavada H.A., Howe P., Ransohoff R.M. Inhibition of interferon-γ-induced major histocompatibility complex class II gene transcription by interferon-β and type β1 transforming growth factor in human astrocytoma cells: Definition of cis-element. J. Biol. Chem. 268:1993;18794-18800.
23. Dhib-Jalbut S., Gogate N., Jiang H., Eisenberg H., Bergey G. Human microglia activate lymphoproliferative responses to recall viral antigens. J. Neuroimmunol. 65:1996;67-73.
24. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H.C., Brosnan C. Microglia and cytokines in neurological disease with special reference to AIDS and Alzheimer's disease. GLIA. 7:1993;75-83.
25. Elkabes S., Dicicco-Bloom E.M., Black I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16:1996;2508-2521.
26. + cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. J. Immunol. 151:1993;38-47.
27. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 307:1984;273-276.
28. Fontes J.D., Jiang B., Peterlin B.M. The class II trans-activator CIITA interacts with the TBP-associated factor TAFll32. Nucleic Acids Res. 25:1997;2522-2528.
29. Ford A.L., Foulcher E., Lemckert F.A., Sedgwick J.D. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. M. 184:1996;1737-1745.
30. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
31. Frohman E.M., Frohman T.C., Dustin M.L., Vayuvegula B., Choi B., Gupta A., Van DenNoort S., Gupta S. The induction of intercellular adhesion molecule1 (ICAM-1) expression on human fetal astrocytes by interferon-γ tumor necrosis factor-α lymphotoxin and interleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 23:1989;117-124.
32. Gay D., Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques: An immunocytological study. Brain. 114:1991;557-572.
33. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J.A., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA. 93:1996;2499-2504.
34. Glimcher L.H., Kara C.J. Sequences and factors: a guide to MHC Class II transcription. Annu. Rev. Immunol. 10:1992;13-49.
35. Gold R., Schmied M., Tontsch U., Hartung H.P., Wekerle H., Toyka K., Lassmann H. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. Brain. 119:1996;651-659.
36. Greenlund A.C., Farrar M.A., Viviano B.L., Schreiber R.D. Ligand-induced IFNγ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13:1994;1591-1600.
37. Greenlund A.C., Morales M.O., Viviano B.L., Yan H., Krolewski J., Schreiber R.D. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity. 2:1995;677-687.
38. Grewal I., Foellmer H., Grewal K., Xu J., Hardardottir F., Baron J., Janeway C., Flavell R. Requirement for CD40 ligand in costimulation induction T cell activation and experimental allergic encephalomyelitis. Science. 273:1996;1864-1867.
39. Grewal I.S., Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:1998;111-135.
40. Grusby M.J., Glimcher L.H. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13:1995;417-435.
41. Guardiola J., Mattei A. Control of MHC class II gene expression in autoimmune infectious and neoplastic diseases. Crit. Rev. Immunol. 13:1993;247-268.
42. Heese K., Hock C., Otten W. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70:1998;699-707.
43. Henderson A., Calame K. Transcription regulation during B cell development. Annu. Rev. Immunol. 16:1998;163-200.
44. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:1991;254-260.
45. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239:1988;290-292.
46. Hickey W.F., Osborn J.P., Kirby W.M. Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell. Immunol. 91:1985;528-535.
47. Hofman F.M., VonHanwher R., Dinarello C., Mizel S., Hinton D., Merrill J.E. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J. Immunol. 136:1986;3239-3245.
48. Iglesias B.M., Cerase J., Ceracchini C., Levi G., Aloisi F. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-γ and lipopolysaccharide and downregulation by interleukin-10 prostaglandin E2 and cyclic AMP-elevating agents. J. Neuroimmunol. 72:1997;83-93.
49. Issazadeh S., Navikas V., Schaub M., Sayegh M., Khoury S. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161:1998;1104-1112.
50. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. The B7 and CD28 receptor families. Immunol. Today. 15:1994;321-331.
51. Kang S., Liang L., Parker C.D., Collawn J.F. Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting. J. Biol. Chem. 273:1998;20644-20652.
52. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
53. Kern I., Steimle V., Siegrist C.A., Mach B. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Inter. Immunol. 7:1995;1295-1299.
54. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β interleukin 4 and prostaglandin E expression in the brain. J. Exp. M. 176:1992;1355-1364.
55. Kotenko S.V., Izotova L.S., Pollack B.P., Mariano T.M., Donnelly R., Muthukumaran G., Cook J.R., Garotta G., Silvennoinen O., Ihle J., Pestka S. Interaction between the components of the interferon γ receptor complex. J. Biol. Chem. 270:1995;20915-20921.
56. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
57. Kuruvilla A.P., Shah R., Hochwald G.M., Liggitt H.D., Palladino M., Thorbecke G.J. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA. 88:1991;2918-2921.
58. Lamb C.A., Yewdell J.W., Bennick J.R., Cresswell P. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc. Natl. Acad. Sci. USA. 88:1991;5998-6002.
59. Lee S.C., Moore G.R.W., Golenwsky G., Raine C.S. Multiple sclerosis: A role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 49:1990;122-136.
60. Lee Y.J., Benveniste E.N. STAT-1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J. Immunol. 157:1996;1559-1568.
61. Lee Y.J., Han Y., Lu H.T., Nguyen V., Qin H., Howe P.H., Hocevar A., Boss J.M., Ransohoff R.M., Benveniste E.N. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:1997;2065-2075.
62. Lenschow D.J., Ho S.C., Sattar H., Rhee L., Gray G., Nabavi N., Herold K.C., Bluestone J.A. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. M. 191:1995;1145-1155.
63. Lotteau V., Teyton L., Peleraux A., Nilsson T., Karlsson L., Schmid S., Quaranta V., Peterson P.A. Intracellular transport of class II MHC molecules directed by invariant chain. Nature. 348:1990;600-605.
64. Lu H.T., Riley J.L., Babcock G.T., Huston M., Stark G.R., Boss J., Ransohoff R.M. Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein ISGF3-γ J. Exp. M. 182:1995;1517-1525.
65. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:1996;301-331.
66. Mahanta S.K., Scholl T., Yang F.C., Strominger J.L. Transactivation by CIITA the type II bare lymphocyte syndrome-associated factor requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA. 94:1997;6324-6329.
67. Marsters S.A., Pennica D., Bach E., Schreiber R.D., Ashkenazi A. Interferon γ signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc. Natl. Acad. Sci. USA. 92:1995;5401-5405.
68. Matsumoto Y., Kawai K., Fujiwara M. In situ Ia expression on brain cells in the rat: Autoimmune encephalomyelitis-resistant strain (BN) and susceptible strain (Lewis) compared. Immunology. 66:1989;621-627.
69. Matsumoto Y., Ohmori K., Fujiwara M. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology. 76:1992;209-216.
70. Mc Combe P.A., DeJersey J., Pender M.P. Inflammatory cells microglia and MHC class II antigen-positive cells in the spinal cord of Lewis rats with acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 51:1994;153-167.
71. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., McGeer E. Microglia in degenerative neurological disease. GLIA. 7:1993;84-92.
72. Meraz M., White J.M., Sheehan K.C.F., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., Dubois R.N., Clark R., Aguet M., Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:1996;431-442.
73. Mond J.J., Carman J., Sarma C., Ohara J., Finkelman F.D. Interferon-γ suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. J. Immunol. 137:1986;3534-3537.
74. Muhlethaler-Mottet A., DiBerardino W., Otten L.A., Mach B. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity. 8:1998;157-166.
75. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860.
76. Nathanson J.A., Chun L.L.Y. Immunological function of the blood-cerebrospinal fluid barrier. Proc. Natl. Acad. Sci. USA. 86:1989;1684-1688.
77. Neumann H., Boucraut J., Hahnel C., Misgeld T., Wekerle H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur. J. Neurosci. 8:1996;2582-2590.
78. Neumann H., Misgeld T., Matsumuro K., Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc. Natl. Acad. Sci. USA. 95:1998;5779-5784.
79. Nguyen V., Walker W.S., Benveniste E.N. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-β Eur. J. Immunol. 28:1998;2537-2548.
80. Nikcevich K.M., Gordon K.B., Tan L., Hurst S.D., Kroepfl J.F., Gardinier M., Barrett T.A., Miller S.D. IFN-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:1997;614-621.
81. O'Keefe G.M., Nguyen V., Benveniste E.N. CIITA and class II MHC gene expression in microglia: modulation by the cytokines TGF-β, IL-4, IL-13 and IL-10. Eur. J. Immunol. 29:1999;1275-1285.
82. Odorizzi C.G., Trowbridge I.S., Xue L., Hopkins C.R., Davis C.D., Collawn J.F. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol. 126:1994;317-330.
83. Otten L.A., Steimle V., Bontron S., Mach B. Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 28:1998;473-478.
84. Rohn W., Tang L.P., Dong Y., Benveniste E.N. IL-1β inhibits IFN-γ induced class II MHC expression by suppressing transcription of the class II transactivator gene. J. Immunol. 162:1999;886-896.
85. Rohn W.M., Lee Y.J., Benveniste E.N. Regulation of class II MHC expression. Crit. Rev. Immunol. 16:1996;311-330.
86. Rosenman S.J., Shrikant P., Dubb L., Benveniste E.N., Ransohoff M. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154:1995;1888-1899.
87. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
88. Saoudi A., Simmonds S., Huitinga I., Mason D. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. M. 182:1995;335-344.
89. Satoh J.I., Lee Y.B., Kim S.U. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res. 704:1995;92-96.
90. Scholl P.R., Geha R.S. MHC class II signaling in B-cell activation. Immunol. Today. 15:1994;418-422.
91. Scholl T., Mahanta S.K., Strominger J.L. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA. 94:1997;6330-6334.
92. + T cell responses in the central nervous system. J. Exp. M. 173:1991;1235-1246.
93. Shrikant P., Benveniste E.N. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 157:1996;1819-1822.
94. Shrikant P., Chung I.Y., Ballestas M., Benveniste E.N. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α interleukin-1β and interferon-γ in astrocytes. J. Neuroimmunol. 51:1994;209-220.
95. Shrikant P., Weber E., Jilling T., Benveniste E.N. ICAM-1 gene expression by glial cells: differential mechanisms of inhibition by interleukin-10 and interleukin-6. J. Immunol. 155:1995;1489-1501.
96. Silacci P., Mottet A., Steimle V., Reith W., Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. M. 180:1994;1329-1336.
97. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 75:1993;135-146.
98. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B. Mach Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science. 265:1994;106-109.
99. Swanborg R.H. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77:1995;4-13.
100. Tan L., Gordon K.B., Mueller J.P., Matis L.A., Miller S.D. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes. J. Immunol. 160:1998;4271-4279.
101. Ting J.P.Y., Baldwin A.S. Regulation of MHC gene expression. Current Opin. Immunol. 5:1993;8-16.
102. Van DerVeen R.C., Stohlman S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:1993;213-220.
103. Vass K., Lassmann H. Intrathecal application of interferon gamma. Amer. J. Pathol. 137:1990;789-800.
104. Vidovic M., Sparacio S.M., Elovitz M., Benveniste E.N. Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α J. Neuroimmunol. 30:1990;189-200.
105. Weber F., Meinl E., Aloisi F., Nevinny-Stickel C., Albert E., Wekerle Hohlfeld R. Human astrocytes are only partially competent antigen presenting cells. Brain. 117:1994;59-69.
106. Williams K., Ulvestad E., Antel J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:1994;3031-3037.
107. Williams K.C., Dooley N.P., Ulvestad E., Waage A., Blain M., Yong V., Antel J.P. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J. Neurosci. 15:1995;1869-1878.
108. Winghagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., Hafler D.A. Expression of costimulatory molecules B7-1 (CD80) B7-2 (CD86) and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. M. 182:1995;1985-1996.
109. Wong G.H.W., Bartlett P.F., Clark-Lewis I., Battye F., Schrader W. Inducible expression of H-2 and Iα antigens on brain cells. Nature. 310:1984;688-691.
110. Wright K.L., Chin K.C., Linhoff M., Skinner C., Brown J.A., Boss J., Stark G.R., Ting J.P.Y. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;6267-6272.